<html>
<head>PUBMED IDs for KDM1B</head>
<body bgcolor='#C5F0F2'><h1>KDM1B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23260659/'>LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation.</a> April 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24924415/'>Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.</a> August 19  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26226427/'>A rationally-designed chimeric KDM1A/KDM1B histone demethylase tower domain deletion mutant retaining enzymatic activity.</a> October 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26766590/'>MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.</a> May 26  2016<br></body></html>
